10x Genomics Inc
For the period ended Dec 31, 2024. Filed Feb 13, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Feb 13, 2025
TXG$62.90-3.3%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 8. Financial Statements and Supplementary Data
Index to Consolidated Financial Statements
| Page | |
|---|---|
| Reports of Independent Registered Public Accounting Firm (PCAOB ID No. 42) | 77 |
| Consolidated Balance Sheets | 79 |
| Consolidated Statements of Operations | 80 |
| Consolidated Statements of Comprehensive Loss | 81 |
| Consolidated Statements of Stockholders’ Equity | 82 |
| Consolidated Statements of Cash Flows | 83 |
| Notes to Consolidated Financial Statements | 84 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.